[ad_1] Aimovig is a development of Novartis and Amgen. The launch in the US has been unprecedented, said Novartis boss Vas Narasimhan, who calls it a good omen for the launch in …
Read More »First antibody approved for migraine prophylaxis
[ad_1] The European Commission has approved Novartis for the monoclonal antibody Erenumab (Aimovig ® ). The product is indicated for the prophylaxis of migraine in adult patients with migraine for at least …
Read More »